血栓弹力图血小板映射生物标志物预测自发性脑出血后血肿扩大
本研究为三中心观察性队列研究,纳入35例自发性脑出血患者,采用血栓弹力图6s血小板映射检测血小板活性生物标志物。结果显示肝素化高岭土加肝素酶与血肿扩大呈负相关(ρ=-0.34,P=0.02),ActF与血肿扩大的关联受院前抗血小板药物使用影响(交互P=0.005)。
要点
- 血栓弹力图血小板映射生物标志物可预测后续血肿扩大。
- 肝素化高岭土加肝素酶与血肿扩大负相关(ρ=-0.34,P=0.02)。
- ActF与血肿扩大的关联受院前抗血小板药物使用影响(交互P=0.005)。
核心结论
- 血栓弹力图6s血小板映射测定的止血生物标志物可预测后续血肿扩大,可能有助于判断神经外科手术需求。
- 增强血小板介导的凝血可能是减少血肿扩大和改善脑出血结局的靶点。
研究设计与样本
- 三中心观察性队列研究,纳入35例自发性脑出血患者,进行多次影像扫描以计算血肿扩大。
- 采用血栓弹力图6s血小板映射检测血小板活性,使用Spearman秩相关分析血肿扩大与血小板活性的相关性,并用线性回归模型以ActF预测血肿扩大。
主要发现
- 肝素化高岭土加肝素酶与血肿扩大呈负相关(ρ=-0.34,P=0.02),提示血小板-纤维蛋白凝块更强与后续血肿扩大更少相关。
- ActF与血肿扩大的关联取决于院前抗血小板药物使用(交互P=0.005);在未使用院前抗血小板药物的患者中,ActF(纤维蛋白原)越高与血肿扩大越少相关。
关键数值与推荐
- 血栓弹力图6s血小板映射评估3种生物标志物:二磷酸腺苷受体诱导的血小板活化、肝素化高岭土加肝素酶测定的血小板-纤维蛋白网络凝块强度、激活剂F(ActF)测定的仅纤维蛋白原凝块强度。
临床怎么用
- 血栓弹力图6s血小板映射生物标志物可能辅助预测自发性脑出血后血肿扩大,并帮助判断神经外科手术需求。
- ActF与血肿扩大的关联受院前抗血小板药物使用影响,解读时需结合用药史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hematoma expansion (HE) is a preventable cause of disability and death in patients with acute intracerebral hemorrhage (ICH). Platelet activity is essential for coagulation, and antiplatelet medications (eg, aspirin, clopidogrel) increase HE risk. General markers of platelet activity are associated with later HE, but specific biomarkers of platelet activity could enhance our understanding. We hypothesized that hemostatic biomarkers of platelet activity would correlate with later HE. METHODS: We conducted a tri-center observational cohort study of spontaneous ICH patients with multiple imaging scans for HE calculation. The thromboelastography 6s Platelet Mapping assay assessed platelet activity with 3 biomarkers: (1) adenosine diphosphate receptor-induced platelet activation, (2) platelet-fibrin network clot strength measured by heparinized kaolin with heparinase, and (3) fibrinogen-only clot strength measured by activator F (ActF). Spearman rank measured the correlation between HE and platelet activity. A linear regression model predicted HE from ActF. We tested whether the relationship between ActF and HE interacted with pre-ICH antiplatelet medication. RESULTS: Thirty-five patients were included. Eleven (35.48%) took pre-ICH antiplatelet medication. Heparinized kaolin with heparinase negatively correlated with HE (ρ=-0.34, P=0.02), indicating that stronger platelet-fibrin clots were associated with less subsequent HE. ActF's association with HE depended on pre-ICH antiplatelet medication use (interaction P=0.005). More ActF (fibrinogen) was associated with less HE in patients who did not take pre-ICH antiplatelet medication. CONCLUSIONS: Hemostatic biomarkers from the thromboelastography 6s Platelet Mapping assay predicted subsequent HE and may aid in determining neurosurgical need. Strengthening platelet-mediated coagulation may be a target for reducing HE and improving ICH outcomes.
引用
- Copenhaver KM, Silva Pinheiro do Nascimiento J, Garg RK, et al. Biomarkers of Thromboelastography Platelet Mapping Predict Hematoma Expansion After Spontaneous Intracerebral Hemorrhage. Stroke. 2025. PMID: 40677225. doi:10.1161/STROKEAHA.125.051447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。